These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 33106318)

  • 1. Modeling neurodegeneration in
    Caldwell KA; Willicott CW; Caldwell GA
    Dis Model Mech; 2020 Oct; 13(10):. PubMed ID: 33106318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in
    Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA
    J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of
    Liang JJH; McKinnon IA; Rankin CH
    J Neurogenet; 2020; 34(3-4):527-548. PubMed ID: 32772603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling neurodegenerative diseases in Caenorhabditis elegans.
    Li J; Le W
    Exp Neurol; 2013 Dec; 250():94-103. PubMed ID: 24095843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Watching worms whither: modeling neurodegeneration in C. elegans.
    Wolozin B; Gabel C; Ferree A; Guillily M; Ebata A
    Prog Mol Biol Transl Sci; 2011; 100():499-514. PubMed ID: 21377635
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Roussos A; Kitopoulou K; Borbolis F; Palikaras K
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nematode Caenorhabditis elegans: a versatile model for the study of proteotoxicity and aging.
    Volovik Y; Marques FC; Cohen E
    Methods; 2014 Aug; 68(3):458-64. PubMed ID: 24794346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live Animal Imaging and Cell Sorting Methods for Investigating Neurodegeneration in a C. elegans Excitotoxic Necrosis Model.
    Mendelowitz ZZ; Idrizi A; Mano I
    J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
    Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
    J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenic
    Griffin EF; Scopel SE; Stephen CA; Holzhauer AC; Vaji MA; Tuckey RA; Berkowitz LA; Caldwell KA; Caldwell GA
    Dis Model Mech; 2019 Feb; 12(2):. PubMed ID: 30683808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A predictable worm: application of Caenorhabditis elegans for mechanistic investigation of movement disorders.
    Dexter PM; Caldwell KA; Caldwell GA
    Neurotherapeutics; 2012 Apr; 9(2):393-404. PubMed ID: 22403010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseases.
    Ma L; Zhao Y; Chen Y; Cheng B; Peng A; Huang K
    Eur J Pharmacol; 2018 Jan; 819():169-180. PubMed ID: 29208474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.
    Griffin EF; Caldwell KA; Caldwell GA
    ACS Chem Neurosci; 2017 Dec; 8(12):2596-2606. PubMed ID: 29022701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model.
    Guha S; Fischer S; Johnson GVW; Nehrke K
    Mol Neurodegener; 2020 Nov; 15(1):65. PubMed ID: 33168053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
    Bates EA; Victor M; Jones AK; Shi Y; Hart AC
    J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans.
    Wang YA; Kammenga JE; Harvey SC
    Hum Genomics; 2017 May; 11(1):12. PubMed ID: 28545550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic animal models of neurodegeneration based on human genetic studies.
    Harvey BK; Richie CT; Hoffer BJ; Airavaara M
    J Neural Transm (Vienna); 2011 Jan; 118(1):27-45. PubMed ID: 20931247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards Understanding Neurodegenerative Diseases: Insights from
    Wu Y; Chen Y; Yu X; Zhang M; Li Z
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices.
    Youssef K; Tandon A; Rezai P
    Integr Biol (Camb); 2019 May; 11(5):186-207. PubMed ID: 31251339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
    Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.